Disease
Obesity
Chronic disease of excess adiposity (BMI >=30), a primary driver and comorbidity accelerant across cardiometabolic conditions.
Total attributable cost
$199.1B
$1,861/patient
Drug spend
$10.6B
$99/patient
5% of total cost is drugs
BMI >=30 (or >=27 with a weight-related comorbidity) · US